Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
Genentech sticks 2nd molecular glue deal with Orionis worth $2B
Roche's Genentech is sticking with Orionis Biosciences, handing over $105 million upfront as part of its second deal with the molecular glue biotech.
James Waldron
May 21, 2025 8:30am
Revised Blueprint-VantAI deal turns focus to molecular glues
May 20, 2025 10:32am
AbbVie tosses ADARx $335M for siRNA options deal
May 14, 2025 9:00am
Sanofi axes IGM pact, sparking 80% layoffs at the biotech
May 9, 2025 3:59am
Ferrer nabs European rights for ALS asset in €500M pact
Apr 28, 2025 2:40pm
Genentech builds autoimmune Repertoire with $765M deal
Apr 23, 2025 7:00am
